Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Clinical trial NCT05350592 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05350592
- Sponsor
- Rigshospitalet, Denmark
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-13
- Primary completion
- 2025-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.